ORDERING INFORMATION

LENGTH POST-
STENT
DILATATION
DIAMETER
8 mm 12 mm 15 mm 18 mm 23 mm 28 mm 33 mm 38 mm LIMIT

2.0 mm 1508200-08 1508200-12 1508200-15 1508200-18 1508200-23 1508200-28 1508200-33 1508200-38 3.75 mm

XIENCE™ STENT: MOST STUDIED, 2.25 mm 1508225-08 1508225-12 1508225-15 1508225-18 1508225-23 1508225-28 1508225-33 1508225-38 3.75 mm

MOST IMPLANTED STENT IN THE WORLD 2.5 mm 1508250-08 1508250-12 1508250-15 1508250-18 1508250-23 1508250-28 1508250-33 1508250-38 3.75 mm

2.75 mm 1508275-08 1508275-12 1508275-15 1508275-18 1508275-23 1508275-28 1508275-33 1508275-38 3.75 mm

3.0 mm 1508300-08 1508300-12 1508300-15 1508300-18 1508300-23 1508300-28 1508300-33 1508300-38 3.75 mm

3.25 mm 1508325-08 1508325-12 1508325-15 1508325-18 1508325-23 1508325-28 1508325-33 1508325-38 3.75 mm

15
DAPT 3.5 mm 1508350-08 1508350-12 1508350-15 1508350-18 1508350-23 1508350-28 1508350-33 1508350-38 5.5 mm

120+
Studied in 4.0 mm 1508400-08 1508400-12 1508400-15 1508400-18 1508400-23 1508400-28 1508400-33 1508400-38 5.5 mm

MILLION+ Clinical Trials1

20,000+ STENT SPECIFICATIONS DELIVERY SYSTEM SPECIFICATIONS

Implants 1
Patients 2
Stent Design
MULTI-LINK, 3-3-3,
Nominal Pressure
9 atm for 2.25-2.5 mm;
Peak-to-Valley Design 12 atm for 2.75-4.0 mm

Stent Material L-605 Cobalt Chromium Rated Burst Pressure 16 atm for All Diameters

STOPDAPT2

10+
Proximal Distal
Drug Everolimus Shaft Measurements
Study 2.1F/0.71 mm 2.7F/0.89 mm

125,000+ 0.1% Drug Dose 1 µg/mm2 Min. GC/Sheath Diameter 5F/0.056"/1.42 mm

Patients Studied 1
Years of Data
Definite stent thrombosis at
Polymer Fluorinated Copolymer Balloon Material Pebax‡ 72D

1 year after 1 month

Strut Thickness 0.0032" (81 µm) Crossing Profile 0.039" (3.0 x 18 mm)
of DAPT3
MR Conditional
MRI Compatibility Tip Entry Profile 0.017" (3.0 x 18 mm)
(see IFU for specific conditions)

Shortening 0% (maximum expansion) 1 Working Catheter Length 145 cm

Sizes Post-Dil Limit

Post-Dilatation Limit 2.25-3.25 mm 3.75 mm
3.5-4.0 mm 5.5 mm

1. Test(s) performed by and data on file at Abbott

CAUTION: This product is intended for use by or under the direction of a physician.
Redefining deliverability in complex lesions
Prior to use, reference the Instructions for Use, inside the product carton (when available)
or at www.vascular.eifu.abbott or at medical.abbott/manuals for more detailed information on
Indications, Contraindications, Warnings, Precautions and Adverse Events.
Information contained herein for DISTRIBUTION outside the U.S. only. Check the
regulatory status of the device in areas where CE marking is not the regulation in force.
Illustrations are artist’s representations only and should not be considered as engineering
drawings or photographs. Photos on file at Abbott.
Abbott International BVBA
1. 15,000,000 implants number is based on data of DES implants through Q1 2020. Data on file at Abbott. Park Lane, Culliganlaan 2B, 1831 Diegem, Belgium, Tel: 32.2.714.14.11
2. Généreux P, et al. Circ Cardiovasc Interv. 2015;8(5):1-16; Natsuaki et al., Cardiovasc Interv and Ther. 2016. 31:196–209; Watanabe H, et al. Information contained herein for DISTRIBUTION outside of the U.S. only.
™ Indicates a trademark of the Abbott Group of Companies.
JAMA. 2019;321(24):2414-2427; Hahn J, et al. ACC 2019 – SMART CHOICE; Valgimigli M, et al. Circulation. 2012;125:2015-2026; Gilard M, ‡ Indicates a third-party trademark, which is property of its respective owner. Check the regulatory status of the device in areas where CE marking is not
et al. J Am Coll Cardiol 2015;65:777-786; Hong SJ, et al. J Am Coll Cardiol Intv. 2016;9:1438–1446. Gwon HC, et al. ACC 2011 - EXCELLENT. www.cardiovascular.abbott
the regulation in force.
3. Watanabe H, et al. JAMA. 2019;321(24):2414-2427 - STOPDAPT 2. ©2020 Abbott. All rights reserved. MAT-2010444 v1.0 ©2020 Abbott. All rights reserved. MAT-2010444 v1.0
Redefining deliverability in complex lesions

XIENCE PRO™ S STENT DESIGN SPECIFICALLY DESIGNED FOR

THE TREATMENT OF EVEN COMPLEX PATIENTS
SLIM FLEX TECHNOLOGY
Includes tight crests and smooth
links that allow tighter crimping
for low crossing profile1
PRECISE
LARGE VESSELS SIDE BRANCH ACCESS RADIAL ACCESS
• 100% accurate marker placement1 • P
 ost-dilatation up to 5.5 mm 1
• L
 argest side branch access in • U
 nsurpassed pushability:
• Zero shortening for precise stent placement2 • S
 uperior coating2 integrity, workhorse sizes2 Requires less force to cross
ELONGATED BAR ARMS even at max expansion3 • S
 tent design maintains integrity lesion4
• Z
 ero shortening3 even when cell is opened4 • 5
 French compatible
Deliver up to 5.5 mm maximum
• U
 ltra low crossing profile4
STRONG expansion in 3.5 mm and
4.0 mm diameter sizes1
• Great longitudinal strength1
• Outstanding stent retention1
• Robust radial strength1

CTO DIABETES
SLIM • T
 rue Center Tip designed • L
 ong lengths for small vessels
STENT DELIVERY succeed in CTOs • L
 ess force needed to cross
• Ultra low crossing profile3 SYSTEM FOR COMPLEX CASES • U
 ltra low crossing profile4 tight lesions4
• T
 he only CTO-indicated stent • P
 roven safety and efficacy in
Design innovations built to provide the • U
 nrivaled safety in CTOs5 diabetic patients6
flexibility, crossability, and pushability
ULTRA LOW CROSSING PROFILE3 needed for even the most complex cases

MAXIMAL EXPANSION1
XIENCE Resolute XIENCE
Synergy‡
Pro™ A Onyx‡
0.0393"
Pro™ S Up to 5.5 mm in large sizes
0.0425" 0.0405" 0.0390"

1. Test(s) performed by and data on file at Abbott. 5.5 mm maximum expansion in 3.5 and 4.0 diameter sizes.
2. Test(s) performed by and data on file at Abbott.
3. Test(s) performed by and data on file at Abbott. Refers to 4.0 mm diameter size expanded to 5.5 mm.
4. Test(s) performed by and data on file at Abbott. 3.0 mm diameter size tested, compared to XIENCE Pro A, Synergy, Resolute Onyx.
1. Data on file at Abbott. 5. EXPERT CTO Trial data demonstrated 1% definite stent thrombosis and 6.3% TLR at 1 year. Kandzari D, et al.
2. Test(s) performed by and data on file at Abbott. Refers to 4.0 mm diameter size expanded to 5.5 mm. “Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization.” JACC 2015.
3. Test(s) performed by and data on file at Abbott. 3.0 mm diameter size tested, compared to XIENCE Pro A, Synergy, Resolute Onyx. 1. Test(s) performed by and data on file at Abbott. 6. TUXEDO 2-Year Data, Upendra Kaul, TCT 2016.